{"symbol":"GILD","fiscalQuarter":"Q4-2018","reportDate":"2019-02-04","reportTime":"AMC","status":"reported","company":{"name":"Gilead Sciences, Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/GILD/earnings/Q4-2018","postBrief":{"headline":"Gilead Sciences Misses on EPS, Stock Down N/A%","keyNumbers":[{"metric":"EPS","actual":"$1.44","expected":"N/A","surprise":"-19.16%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management highlighted challenges in the market affecting performance.","They emphasized a focus on long-term strategies despite short-term hurdles."],"summary":"Management expressed concerns about current market conditions impacting results. They remain focused on long-term growth strategies."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"The earnings report indicates that Gilead Sciences faced challenges in the fourth quarter, leading to a notable miss on EPS. The lack of revenue data and guidance may leave investors uncertain about the company's near-term prospects. The stock reaction is not available, but the defensive tone from management suggests caution moving forward.","metaDescription":"Gilead Sciences (GILD) Q4 2018 earnings: EPS missed expectations. Stock reaction not available. Full breakdown."}}